<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20251118068036N5</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-06-11</date_registration>
      <primary_sponsor>Hamedan University of Medical Sciences</primary_sponsor>
      <public_title>Studying the effect of using patient dentin particles in preserving bone at the site of tooth extraction</public_title>
      <acronym></acronym>
      <scientific_title>Studying the effect of using autologous dentin particles on maintaining tooth sockets in patients referring to Hamedan Dental School</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-07-04</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>18</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/90728</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Allocation of eligible individuals to the study and control groups is done randomly using equal-sized random blocks. The allocation sequence is prepared by someone outside the treatment and surgical team and placed in sealed, opaque, numbered envelopes. After entering and recording the patient's initial information and before performing the intervention, the relevant envelope is opened and the patient's group is determined, Blinding description: The outcome assessor, who is responsible for reviewing and measuring the CBCT images before the intervention and at the 4-month follow-up, will not be aware of the allocation of patients to the study or control group. The CBCT images will be provided to him/her in a coded form without mentioning the group name. Due to the nature of the intervention, blinding of the patient and surgeon is not possible.</study_design>
      <phase>3</phase>
      <hc_freetext>Maintaining tooth mobility after tooth extraction.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: In this group, after local anesthesia with 2% lidocaine, the maxillary premolar tooth is extracted using a minimally invasive method (atraumatic extraction) with the help of a periotome and fine elevators to preserve the integrity of the socket bone walls. Then, after washing with normal saline, the socket is covered with a collagen membrane (manufactured by Iranian Tissue Products Company). Finally, the edges of the membrane are fixed with non-continuous sutures (Figure of eight) using 4-0 Vicryl thread (Supa Company). Intervention 2: Control group: "In this group, after local anesthesia, the maxillary premolar tooth is extracted using an atraumatic extraction method with minimal damage to the socket bone walls. After cleaning the socket of granulation soft tissues with a surgical curette and rinsing with normal saline, the tooth socket remains empty. Then, to protect the blood clot and prevent soft tissue growth into the socket, the socket opening is covered with a resorbable collagen membrane and the edges of the membrane are fixed using non-continuous (Figure-of-eight) sutures with 4-0 thread. The patient undergoes the same postoperative care protocol after surgery.".</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Nazli Rabinejad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Fahmideh St</address>
        <city>Hamadan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6517838678</zip>
        <telephone>+98 81 3131 0000</telephone>
        <email>nazlirabi@yahoo.com</email>
        <affiliation>Hamedan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Nazli Rabinejad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Shahid Fahmideh St</address>
        <city>Hamadan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6517838678</zip>
        <telephone>+98 81 3131 0000</telephone>
        <email>nazlirabi@yahoo.com</email>
        <affiliation>Hamedan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Presence of unmaintainable maxillary premolar teeth
The area in question does not have an active infection.
The patient is willing to participate in the study and sign an informed consent form.</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>The presence of inflammation or active infection (Acute Infection) in the area of ​​the tooth in question (so that it prevents the standard restoration process).
Presence of bleeding disorders or use of anticoagulant medications: which may make minimally invasive surgery difficult.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Z48.8</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Encounter for other specified postprocedural aftercare</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: In this group, after local anesthesia with 2% lidocaine, the maxillary premolar tooth is extracted using a minimally invasive method (atraumatic extraction) with the help of a periotome and fine elevators to preserve the integrity of the socket bone walls. Then, after washing with normal saline, the socket is covered with a collagen membrane (manufactured by Iranian Tissue Products Company). Finally, the edges of the membrane are fixed with non-continuous sutures (Figure of eight) using 4-0 Vicryl thread (Supa Company).</i_keyword>
      <i_keyword>Control group: "In this group, after local anesthesia, the maxillary premolar tooth is extracted using an atraumatic extraction method with minimal damage to the socket bone walls. After cleaning the socket of granulation soft tissues with a surgical curette and rinsing with normal saline, the tooth socket remains empty. Then, to protect the blood clot and prevent soft tissue growth into the socket, the socket opening is covered with a resorbable collagen membrane and the edges of the membrane are fixed using non-continuous (Figure-of-eight) sutures with 4-0 thread. The patient undergoes the same postoperative care protocol after surgery."</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The extent of changes in alveolar bone dimensions (bone height and width). Timepoint: Time 1 (Baseline): Just before tooth extraction surgery (initial evaluation stage with CBCT). Time 2 (Follow-up): 4 months after tooth extraction surgery and intervention (final evaluation stage with CBCT). Method of measurement: Measurement method:1. Obtaining CBCT (Cone Beam Computed Tomography) images of the desired area in two stages (before tooth extraction and 4 months after).2. Transferring images to specialized software (such as OnDemand3D or Romexis).3. Accurate measurement of bone height (distance from bone crest to the socket floor or specific landmark points) and bone width (at specific millimeter distances from the crest).4. Comparison of data obtained at two time points by the outcome assessor (who is unaware of the type of intervention/grouping - Single-blind) to calculate the percentage of dimensional changes.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Changes in the width of the alveolar bone at the site of tooth loss. Timepoint: Baseline: Before tooth extraction and intervention, with CBCTFollow-up: 4 months after surgery and intervention, with CBCT. Method of measurement: Bone width is measured in CBCT at a standard location and at predetermined sections. The pre- and post-intervention images are analyzed by dental radiology software and the distance between the buccal and palatal/lingual walls is recorded at specific areas. The amount of change in bone width between the two times is then compared.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Hamedan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-02-14</approval_date>
        <contact_name>Research Ethics Committee of Hamadan University of Medical Sciences</contact_name>
        <contact_address>Shahid Fahmideh St Hamadan Hamadan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
